No open-market buying or selling by insiders.
The last open-market buy by an executive or director was in Oct 2025.
Get an email when SNGX's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Oct 2, 2025 | Christopher J Schaber Chairman, CEO and President | Bought | 15,132 | $1.32 | 20K | 3993% | Form 4 |
- Oct 2, 2025Christopher J SchaberChairman, CEO and President · bought 15,132 at $1.3220K3993% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with SNGX
Spot a number that looks wrong? Check it in SNGX's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing SNGX
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.